Page 125 - Global Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Jan 09, 2025

Explore the Global Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

3,212 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4512

Wakamoto PharmaceuticalLtd
JP¥220.002.3%3.3%JP¥7.5bn/an/an/a1.4%

4882

Perseus Proteomics
JP¥604.002.0%-12.0%JP¥8.7bn/aPS81.7xn/an/a

A229500

NovMetaPharma
₩5,650.000.4%n/a₩50.5bn/an/an/an/a

PHAR

Egyptian International Pharmaceutical Industries
ج.م46.202.7%18.6%ج.م6.9bج.م77.62PE5.9xS15.3%2.2%

A263050

Eutilex.Co.Ltd
₩2,035.000.2%-38.0%₩74.7bn/aPS10.9xn/an/a

SMSLIFE

SMS Lifesciences India
₹1,301.804.9%113.7%₹3.8bn/aPE18xn/a0.1%

HLUN B

H. Lundbeck
DKK 41.360.5%16.7%DKK 39.4bDKK 50.15PE15.3xE7.4%1.7%

UTHR

United Therapeutics
US$366.611.2%67.4%US$16.4bUS$398.02PE14.7xE10.0%n/a

540937

Medico Remedies
₹63.053.8%-27.8%₹5.0bn/aPE68.2xn/an/a

A065660

Anterogen.Co.Ltd
₩19,600.000.1%35.1%₩190.5bn/aPS27.4xn/an/a

300705

Hunan Jiudian Pharmaceutical
CN¥17.192.6%-23.6%CN¥8.3bCN¥32.16PE16.7xE25.3%1.3%

4893

Noile-Immune Biotech
JP¥201.002.6%0.5%JP¥8.5bJP¥440.00PS1243.4xE-14.9%n/a

524731

Jenburkt Pharmaceuticals
₹1,277.554.0%58.2%₹5.4bn/aPE18.6xn/a1.2%

ALIF B

AddLife
SEK 133.601.4%23.4%SEK 16.3bSEK 165.50PE139.2xE52.0%0.4%

A341170

Future Medicine
₩1,178.002.1%-82.4%₩10.7bn/an/an/an/a

300558

Betta Pharmaceuticals
CN¥52.371.0%12.3%CN¥21.7bCN¥56.83PE47.7xE33.4%0.3%

A012790

Sinil Pharmaceutical
₩6,700.000.3%-8.7%₩76.0bn/aPE5.1xn/a2.5%

2437

HARBIN GLORIA PHARMACEUTICALS
CN¥2.454.3%1.7%CN¥5.4bCN¥3.23PE69.6xE35.1%0%

MDGL

Madrigal Pharmaceuticals
US$333.393.1%41.4%US$7.3bUS$373.00PS94.7xE60.0%n/a

ERF

Eurofins Scientific
€49.452.6%-13.6%€9.3b€59.46PE28.5xE18.4%1.0%

ALK B

ALK-Abelló
DKK 153.400.7%42.7%DKK 33.9bDKK 179.20PE43.2xE27.3%0%

4166

Orient Pharma
NT$37.103.1%80.5%NT$8.0bn/aPE69.5xn/an/a

MEDP

Medpace Holdings
US$354.592.2%23.7%US$11.0bUS$347.92PE30.1xE10.9%n/a

3176

Medigen Biotechnology
NT$35.005.4%-17.1%NT$4.6bn/aPS3.5xn/an/a
Page 125 of 134